Inventor · disambiguated record
Stephen T. Schlachter
Also filed as: SCHLACHTER STEPHEN · SCHLACHTER STEPHEN T · SCHLACHTER STEPHEN THOMAS
49 granted patents·15 pending applications·795 citations·filing 1993–2025
98Inventor score
Files withEDGEWISE THERAPEUTICS INC15ARRAY BIOPHARMA INC12PELOTON THERAPEUTICS INC11ICOS CORP6UPJOHN CO5
Top patents by PatentIndex Score
64 records- 0197US8063050B2Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2007·Granted Nov 22, 2011·63 cites·103 claims
- 0297US6022884ASubstituted pyridine compounds and methods of useAMGEN INC·Filed 1998·Granted Feb 8, 2000·207 cites·18 claims
- 0395US11091464B2Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2020·Granted Aug 17, 2021·11 cites·30 claims
- 0495US8003651B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2007·Granted Aug 23, 2011·35 cites·76 claims
- 0595US7179912B2Materials and methods to potentiate cancer treatmentLUITPOLD PHARM INC·Filed 2001·Granted Feb 20, 2007·79 cites·7 claims
- 0694US11236065B2Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2020·Granted Feb 1, 2022·7 cites·30 claims
- 0794US8853199B2Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2011·Granted Oct 7, 2014·20 cites·33 claims
- 0894US6423710B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2000·Granted Jul 23, 2002·47 cites·27 claims
- 0993US12012395B2Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2021·Granted Jun 18, 2024·3 cites·39 claims
- 1093USRE49948EAryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2022·Granted Apr 30, 2024·1 cites·25 claims
- 1193US11390606B2Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2020·Granted Jul 19, 2022·5 cites·25 claims
- 1293US10144711B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2017·Granted Dec 4, 2018·8 cites·20 claims
- 1393US9908845B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2014·Granted Mar 6, 2018·16 cites·28 claims
- 1493US9896418B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2017·Granted Feb 20, 2018·9 cites·20 claims
- 1593US6458813B1Substituted pyridine compounds and methods of useAMGEN INC·Filed 2001·Granted Oct 1, 2002·45 cites·17 claims
- 1692US9969689B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2017·Granted May 15, 2018·8 cites·20 claims
- 1791US12240833B2Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2022·Granted Mar 4, 2025·2 cites·28 claims
- 1890US12240831B2Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2023·Granted Mar 4, 2025·1 cites·51 claims
- 1990US9359340B2Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted Jun 7, 2016·9 cites·101 claims
- 2090US6333341B1Substituted pyridine compounds and methods of useAMGEN INC·Filed 2000·Granted Dec 25, 2001·31 cites·11 claims
- 2189US10597366B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2018·Granted Mar 24, 2020·4 cites·18 claims
- 2288US8846681B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2011·Granted Sep 30, 2014·11 cites·91 claims
- 2387US8329709B25H-cyclopenta[D]pyrimidines as AKT protein kinase inhibitorsBANKA ANNA L·Filed 2009·Granted Dec 11, 2012·10 cites·33 claims
- 2487US6680336B2Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2002·Granted Jan 20, 2004·23 cites·4 claims
- 2586US9884843B2Cyclic sulfone and sulfoximine analogs and uses thereofPELOTON THERAPEUTICS INC·Filed 2014·Granted Feb 6, 2018·9 cites·28 claims
- 2684US6716871B2Cyclic AMP-specific phosphodie sterase inhibitorsICOS CORP·Filed 2002·Granted Apr 6, 2004·14 cites·5 claims
- 2784US6376489B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2000·Granted Apr 23, 2002·22 cites·45 claims
- 2882US8618097B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsBENCSIK JOSEF·Filed 2008·Granted Dec 31, 2013·7 cites·48 claims
- 2981US10807948B2Aromatic compounds and uses thereofPELOTON THERAPEUTICS INC·Filed 2016·Granted Oct 20, 2020·2 cites·18 claims
- 3081US2025223278A1Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3177US8138181B2Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitorsALLEN SHELLEY·Filed 2008·Granted Mar 20, 2012·3 cites·29 claims
- 3277US2022226326A1Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 3377US2025152588A1Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 3476US5981537APyrimidine-thioalkyl and alkylether compoundsUPJOHN CO·Filed 1994·Granted Nov 9, 1999·20 cites·20 claims
- 3576US2025340526A1Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3675US6043248AAlpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptaseUPJOHN CO·Filed 1996·Granted Mar 28, 2000·22 cites·24 claims
- 3775US5397774APyrazolopyrimidine and pyrimidinyl bisphosphonic esters as anti-inflammatoriesUPJOHN CO·Filed 1993·Granted Mar 14, 1995·17 cites·9 claims
- 3873US9409886B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Aug 9, 2016·2 cites·50 claims
- 3972US12448369B2Quinolinone amide compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2024·Granted Oct 21, 2025·0 cites·56 claims
- 4072US2020190031A1Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4171US8895566B25H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2012·Granted Nov 25, 2014·1 cites·34 claims
- 4271US8575145B2Triazolopyridine compounds as PIM kinase inhibitorsALLEN SHELLEY·Filed 2009·Granted Nov 5, 2013·2 cites·29 claims
- 4371US2020345735A1Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 4470US12509431B21,4-dihydroquinazolinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2024·Granted Dec 30, 2025·0 cites·30 claims
- 4569US8404681B2Xanthones, thioxanthones and acridinones as DNA-PK inhibitorsHALBROOK JAMES W·Filed 2004·Granted Mar 26, 2013·7 cites·18 claims
- 4668US12415794B2Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2021·Granted Sep 16, 2025·0 cites·29 claims
- 4766US6998416B2Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2004·Granted Feb 14, 2006·1 cites·2 claims
- 4864US2018169099A1Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Application pending·0 cites
- 4964US2024336609A1Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 5062US9328091B25H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted May 3, 2016·0 cites·3 claims
Showing the top 50 of 64 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stephen T. Schlachter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →